Medplus Health Services Ltd (MEDPLUS) is currently trading at 655.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

MedPlus Health Services Limited is primarily engaged in pharmaceuticals and diagnostic services across India. It operates a vast network of over 5,000 stores, making it the second-largest pharma retailer in the country. The company added 500 stores in the past year, indicating its focus on scaling up operations and increasing market penetration. Its cluster-based expansion strategy emphasizes deepening reach in existing markets. MedPlus reported a significant revenue increase to ₹18,061 million with a 26.2% gross margin, showcasing strong financial performance. The operating EBITDA for pharmacies stood at ₹925 million, maintaining steady growth margins. The integration of a large private label range, both in pharma and non-pharma categories, is a key focus for MedPlus, aimed at enhancing margins and the overall share of wallet. This strategy includes developing its extensive product portfolio. MedPlus demonstrates a clear commitment to omni-channel retailing, leveraging its vast store network to offer competitive services like rapid delivery and lower operational costs, setting it apart from pure online competitors.

Over the past 52 weeks, Medplus Health Services Ltd has traded between a low of ₹645.25 and a high of ₹1,020.35. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Medplus Health Services Ltd has a market capitalization of approximately 7,944.66. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Medplus Health Services Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 37.75 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 7,944.66 Cr, Medplus Health Services Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Medplus Health Services Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Medplus Health Services Ltd is 37.75. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Consolidated net profit was ₹33.18 crore for the quarter ended June 30, down from ₹42.36 crore a year earlier, a decline of about 22%.

The stock rose as much as 11.3% on BSE and hit an intra-day high of ₹1,020.35; at 10:01 AM it was up 8.67% at ₹995.55.

Consolidated net profit was reported at ₹63.98 crore for the quarter ended March 2026, up 24.62% from ₹51.34 crore a year earlier.